Dr. Ozsvath discusses leadership in venous societies, community engagement in vascular care, venous research priorities, and ...
An Abu Dhabi resident has made a full recovery after suffering a rare type of stroke that initially presented as a severe ...
In a recent study of older patients with end-stage kidney disease living in Europe, researchers found o ne-third received an ...
One-third of older patients with end-stage kidney disease received an arteriovenous fistula within 6 months of starting ...
Proven percutaneous AV fistula technology set to re-enter the market with phased rollout in 2026 SAN CLEMENTE, Calif., April 2, 2026 /PRNewswire/ -- Ellipsys Medical, Inc. today announced that the ...
Objective Arteriovenous Fistula (AVF) is the preferred vascular access for patients with Chronic Kidney Disease Stage G5 (CKDG5). Normal AVF function is an important prerequisite for hemodialysis, and ...
Limb-lengthening can add inches to a person’s stature. But its risks have made it controversial. Credit... Supported by By Isabella Kwai Photographs by Matthew Leifheit Isabella Kwai spoke to ...
Diana: Welcome to the Beat, as we await yet another reminder that it's still winter. Let's get right to some innovation news. The Big One Breaking down the day's biggest Inno story. Tech firm lands ...
Company announces positive first-in-human study results, the close of a $6.9 million Series A financing, and FDA approval of its Investigational Device Exemption. ST. LOUIS, Oct. 9, 2025 /PRNewswire/ ...
More than 4 million people worldwide have end-stage kidney disease that requires hemodialysis, a treatment in which a machine filters waste from the blood. Hemodialysis is a precursor to kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results